Company / Current Liabilities
Relay Therapeutics, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$25.6M
FY2025
5-year range
$24.3M / $63.7M
FY2021-FY2025
Trend
-49.6%
vs FY2024
Sector context
#181 of 213
Health Care
What the data says
Relay Therapeutics, Inc.'s current liabilities of $26M is lower than 85% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 7 years, ranging from $12M in FY2019 to $64M in FY2022.
Based on SEC 10-K filings.
$26M in FY2025 with a 5-year CAGR of +13.4%.
Improved from $30M to $26M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -26.2%
- 5-Year CAGR
- +13.4%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 213This company $25.6M Sector average $1.6B
▼
-98.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +13.4%, indicating consistent growth.
- In FY2025, current liabilities decreased 49.6% year-over-year.
- Ranks #181 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.6M | -49.6% |
| FY2024 | $50.7M | +67.6% |
| FY2023 | $30.3M | -52.5% |
| FY2022 | $63.7M | +162.0% |
| FY2021 | $24.3M | +78.4% |
| FY2020 | $13.6M | +13.7% |
| FY2019 | $12.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026